Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • achamess
    Junior Member
    • Apr 2016
    • 5

    #1

    Interpretation of Gene Body Distribution from nuclear RNA-Seq

    Hi all,

    So I just did an experiment using isolated RNA from neuronal nuclei. I used Smart-Seq2 to amplify from ~100 pg of input. I got plenty of cDNA that looked good on the Tapestation (single peak around ~1500 bp, spanning from 500 to 1000 bp). I then used the Nextera XT kit to finish the library prep. I ran as 50 bp SR on the HiSeq 4000.

    I'm doing my QC stuff now after alignment with STAR to the mm10 Genome (UCSC). With respect to the gene body, I got interesting looking plots that I'm not entirely sure how to interpret. Some of the curves dip in the middle, and it looks like there is a slight 5' bias. The Nextera Kit looks funky in the first ~15 bp of the 5' end, but that's expected I've been told.

    Any thoughts? Also, I'll say that I got this plot with RSeQC using a mm10 BED supplied on the site. I know that a large fraction (~40%) of my reads are intron, despite the polyA capture of Smart-Seq2. Could that be influencing the curves?

    Thanks so much.

    Here is the graph ->Graphs Gene Body Distribution Curves

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...